Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers

Si’Ana A. Coggins, Eric D. Laing, Cara H. Olsen, Emilie Goguet, Matthew Moser, Belinda M. Jackson-Thompson, Emily C. Samuels, Simon D. Pollett, David R. Tribble, Julian Davies, Luca Illinik, Monique Hollis-Perry, Santina E. Maiolatesi, Christopher A. Duplessis, Kathleen F. Ramsey, Anatalio E. Reyes, Yolanda Alcorta, Mimi A. Wong, Gregory Wang, Orlando Ortega, Edward Parmelee, Alyssa R. Lindrose, Andrew L. Snow, Allison M.W. Malloy, Andrew G. Letizia, John H. Powers III, Timothy H. Burgess, Christopher C. Broder, Edward Mitre
doi: https://doi.org/10.1101/2021.06.25.21259544
Si’Ana A. Coggins
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric D. Laing
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cara H. Olsen
3Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilie Goguet
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Moser
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belinda M. Jackson-Thompson
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily C. Samuels
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon D. Pollett
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Tribble
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julian Davies
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Illinik
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monique Hollis-Perry
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santina E. Maiolatesi
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A. Duplessis
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen F. Ramsey
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
6General Dynamics Information Technology, Falls Church, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anatalio E. Reyes
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
6General Dynamics Information Technology, Falls Church, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda Alcorta
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
6General Dynamics Information Technology, Falls Church, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mimi A. Wong
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
6General Dynamics Information Technology, Falls Church, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Wang
5Clinical Trials Center, Naval Medical Research Center, Silver Spring, MD, USA
6General Dynamics Information Technology, Falls Church, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orlando Ortega
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Parmelee
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: edward.mitre@usuhs.edu
Alyssa R. Lindrose
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew L. Snow
7Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison M.W. Malloy
8Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew G. Letizia
9Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H. Powers III
10Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy H. Burgess
4Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Broder
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Mitre
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background mRNA COVID-19 vaccines are playing a key role in controlling the COVID-19 pandemic. The relationship between post-vaccination symptoms and strength of antibody responses is unclear.

Objective To determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels.

Design Single center, prospective, observational cohort study.

Setting Participants worked at Walter Reed National Military Medical Center and were seen monthly at the Naval Medical Research Center Clinical Trials Center.

Participants Generally healthy adults that were not severely immunocompromised, had no history of COVID-19, and were seronegative for SARS-CoV-2 spike protein prior to vaccination.

Measures Severity of vaccine-associated symptoms was obtained through participant completed questionnaires. Testing for IgG antibodies against SARS-CoV-2 spike protein and receptor binding domain was conducted using microsphere-based multiplex immunoassays.

Results 206 participants were evaluated (69.4% female, median age 41.5 years old). We found no correlation between vaccine-associated symptom severity scores and vaccine-induced antibody titers one month after vaccination. We also observed that 1) post-vaccination symptoms were inversely correlated with age and weight and more common in women, 2) systemic symptoms were more frequent after the second vaccination, 3) high symptom scores after first vaccination were predictive of high symptom scores after second vaccination, and 4) older age was associated with lower titers.

Limitations Study only observes antibody responses and consists of healthy participants.

Conclusions Lack of post-vaccination symptoms following receipt of the BNT162b2 vaccine does not equate to lack of vaccine-induced antibodies one month after vaccination. This study also suggests that it may be possible to design future mRNA vaccines that confer robust antibody responses with lower frequencies of vaccine-associated symptoms.

Funding This study was executed by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed by the Uniformed Services University of the Health Sciences (USUHS) through a cooperative agreement by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). This project has been funded by the Defense Health Program, U.S. DoD, under award HU00012120067. Project funding for JHP was in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funding bodies have had no role in the study design or the decision to submit the manuscript for publication.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was executed by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed by the Uniformed Services University of the Health Sciences (USUHS) through a cooperative agreement by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). This project has been funded by the Defense Health Program, U.S. DoD, under award HU00012120067. Project funding for JHP was in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funding bodies have had no role in the study design or the decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study protocol was approved by the Uniformed Services University of the Health Sciences Institutional Review Board (FWA 00001628; DoD Assurance P60001) in compliance with all applicable Federal regulations governing the protection of human participants.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Naval Medical Research Center, the Department of Navy, the Department of Defense, the Henry. M. Jackson Foundation for the Advancement of Military Medicine, or the U.S. Government. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.

  • Competing Interests: The authors declare that they have no competing interests. EM, EDL, CCB, AS, AMWM, KMH-P, AGL, CAD, and THB are military Service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C., §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C., §101 defines a U.S. Government work as a work prepared by a military Service member or employee of the U.S. Government as part of that person’s official duties.

  • Ethics approval and consent to participate: This study protocol was approved by the Uniformed Services University of the Health Sciences Institutional Review Board (FWA 00001628; DoD Assurance P60001) in compliance with all applicable Federal regulations governing the protection of human participants.

  • All participants provided written informed consent for participation.

Data Availability

Data are available from the first (S.C.) and corresponding (E.M.) authors upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Si’Ana A. Coggins, Eric D. Laing, Cara H. Olsen, Emilie Goguet, Matthew Moser, Belinda M. Jackson-Thompson, Emily C. Samuels, Simon D. Pollett, David R. Tribble, Julian Davies, Luca Illinik, Monique Hollis-Perry, Santina E. Maiolatesi, Christopher A. Duplessis, Kathleen F. Ramsey, Anatalio E. Reyes, Yolanda Alcorta, Mimi A. Wong, Gregory Wang, Orlando Ortega, Edward Parmelee, Alyssa R. Lindrose, Andrew L. Snow, Allison M.W. Malloy, Andrew G. Letizia, John H. Powers III, Timothy H. Burgess, Christopher C. Broder, Edward Mitre
medRxiv 2021.06.25.21259544; doi: https://doi.org/10.1101/2021.06.25.21259544
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers
Si’Ana A. Coggins, Eric D. Laing, Cara H. Olsen, Emilie Goguet, Matthew Moser, Belinda M. Jackson-Thompson, Emily C. Samuels, Simon D. Pollett, David R. Tribble, Julian Davies, Luca Illinik, Monique Hollis-Perry, Santina E. Maiolatesi, Christopher A. Duplessis, Kathleen F. Ramsey, Anatalio E. Reyes, Yolanda Alcorta, Mimi A. Wong, Gregory Wang, Orlando Ortega, Edward Parmelee, Alyssa R. Lindrose, Andrew L. Snow, Allison M.W. Malloy, Andrew G. Letizia, John H. Powers III, Timothy H. Burgess, Christopher C. Broder, Edward Mitre
medRxiv 2021.06.25.21259544; doi: https://doi.org/10.1101/2021.06.25.21259544

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10020)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2452)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1642)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (312)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4832)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)